{
    "Trade/Device Name(s)": [
        "BD Preset\u2122 Syringe",
        "BD A-Line\u2122 Syringe"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K202446",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022426"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA"
    ],
    "Summary Letter Date": "September 25, 2020",
    "Summary Letter Received Date": "August 26, 2020",
    "Submission Date": "August 25, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "coagulation",
        "misc"
    ],
    "Analyte(s)": [
        "pH",
        "blood gases",
        "electrolytes",
        "ionized calcium",
        "metabolites",
        "co-oximetry"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "BD Preset\u2122 Syringe",
        "BD A-Line\u2122 Syringe"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Specimen collection via syringe"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for BD Preset\u2122 Syringe and BD A-Line\u2122 Syringe as blood specimen collection devices for in vitro diagnostic testing",
    "Indications for Use Summary": "Sterile, single use devices intended for collection of whole blood specimens for in vitro diagnostic testing including pH, blood gases, electrolytes, metabolites, and co-oximetry",
    "fda_folder": "Clinical Chemistry"
}